This inventor holds 1 USPTO granted patent. Top assignee: Hoffmann-La Roche Inc.. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001
Title: Max Gerecke-Jecklin: Innovator in Hydroxymethylimidazodiazepines
Introduction
Max Gerecke-Jecklin is a notable inventor based in Reinach, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anxiolytic and anticonvulsant compounds.
Latest Patents
Max Gerecke-Jecklin holds 1 patent for his invention titled "Hydroxymethylimidazodiazepines and their esters." This invention focuses on hydroxymethyl-imidazodiazepines and their esters, which can serve as anxiolytic, anticonvulsant, muscle relaxant, and sedative-hypnotic active substances.
Career Highlights
He is currently employed at Hoffmann-La Roche Inc., a leading global healthcare company. His work at this esteemed organization has allowed him to further his research and development efforts in the pharmaceutical industry.
Collaborations
Throughout his career, Max has collaborated with esteemed colleagues such as Rene Borer and Bernd Büttelmann. These partnerships have contributed to the advancement of innovative solutions in their field.
Conclusion
Max Gerecke-Jecklin's work in the development of hydroxymethylimidazodiazepines showcases his commitment to advancing medical science. His contributions continue to impact the pharmaceutical landscape positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile